| Aug 17, 2026 | Benjamin Hohl | CHIEF FINANCIAL OFFICER | SELL | 6.018K | $58.58 | $353K |
| Aug 17, 2026 | Louise Helen Collins | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $30.53 | $281K |
| Aug 4, 2026 | Mika Derynck | — | SELL-OPTIONS | — | $35.53 | $7.8M |
| Jul 17, 2026 | Benjamin Hohl | CHIEF FINANCIAL OFFICER | SELL | 4.946K | $27.56 | $314K |
| Jul 17, 2026 | Louise Helen Collins | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $27.58 | $251K |
| Jul 6, 2026 | Anne Lori Kunkel | — | SELL | 10.000K | $50.49 | $505K |
| Jun 22, 2026 | ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC | 10% OWNER | SELL | 860.123K | $45.36 | $39.0M |
| Jun 17, 2026 | Benjamin Hohl | CHIEF FINANCIAL OFFICER | SELL-OPTIONS | — | $23.14 | $249K |
| Jun 17, 2026 | Louise Helen Collins | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $23.14 | $207K |
| Jun 15, 2026 | ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC | 10% OWNER | SELL | 281.408K | $45.02 | $12.7M |
| Jun 5, 2026 | Anne Lori Kunkel | — | SELL | 10.000K | $34.54 | $345K |
| May 18, 2026 | Louise Helen Collins | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $21.14 | $187K |
| Apr 17, 2026 | Louise Helen Collins | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $25.08 | $226K |
| Mar 25, 2026 | Louise Helen Collins | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $18.79 | $1.3M |
| Mar 17, 2026 | Louise Helen Collins | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $15.12 | $126K |
| Mar 9, 2026 | Louise Helen Collins | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $16.27 | $1.1M |
| Mar 6, 2026 | Benjamin Hohl | CHIEF FINANCIAL OFFICER | SELL | 10.000K | $29.58 | $296K |